AstraZeneca puts Brilinta, Bydureon on pay-for-performance bandwagon with Harvard Pilgrim deals

30th May 2017 Uncategorised 0

Pay-for-performance deals have been gaining popularity among drugmakers eager to snag payer favor for their meds, and Harvard Pilgrim has been ready and willing to strike up partnerships. The latest to join hands with the PBM? AstraZeneca.

More: AstraZeneca puts Brilinta, Bydureon on pay-for-performance bandwagon with Harvard Pilgrim deals
Source: fierce